Akhil Santhosh: RADIOSA Trial Results in Oligorecurrent Prostate Cancer
bmhcalicut/Instagram

Akhil Santhosh: RADIOSA Trial Results in Oligorecurrent Prostate Cancer

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared on X:

“Addition of 6 months short course ADT to SBRT significantly improves Biochemical PFS in hormone sensitive oligorecurrent prostate cancer as per RADIOSA trial.”

Akhil Santhosh: RADIOSA Trial Results in Oligorecurrent Prostate Cancer

More posts featuring Akhil Santhosh.